| Geisinger Multi-spec Clinic Podiatr | |
| 1155 E Mountain Blvd, Wilkes Barre, Pennsylvania 18702 | |
| (570) 214-5096 |
| Name | Geisinger Multi-spec Clinic Podiatr |
|---|---|
| Organization Name | Geisinger Wyoming Valley Medical Center |
| Location | 1155 E Mountain Blvd, Wilkes Barre, Pennsylvania 18702 |
| Type | Supplier |
| Phone | (570) 214-5096 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cancer Research UK scientists have been part of an international collaboration that has revealed the structure of a protein found in simple yeast cells and shown how it flags up damaged DNA for repair. The results of their study are published in Nature*. The finding may provide clues as to how some cancer cells become resistant to certain chemotherapy drugs.
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
AuthenTec, a leading provider of security, identity management and touch control solutions, and privately-held UPEK, a leading supplier of fingerprint solutions for consumer, business and government applications, announced that the companies have combined, creating the world's largest provider of fingerprint sensors and identity management software, as well as biometric and embedded security solutions.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
› Verified 1 days ago
News Archive
Cancer Research UK scientists have been part of an international collaboration that has revealed the structure of a protein found in simple yeast cells and shown how it flags up damaged DNA for repair. The results of their study are published in Nature*. The finding may provide clues as to how some cancer cells become resistant to certain chemotherapy drugs.
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
AuthenTec, a leading provider of security, identity management and touch control solutions, and privately-held UPEK, a leading supplier of fingerprint solutions for consumer, business and government applications, announced that the companies have combined, creating the world's largest provider of fingerprint sensors and identity management software, as well as biometric and embedded security solutions.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
› Verified 1 days ago
Cvs Caremark Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1 Great Valley Blvd, Wilkes Barre, Pennsylvania 18706 Phone: (866) 823-5184 | |
Cooks Medical Care Company Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 421 N. Pennsylvania Ave, Wilkes Barre, Pennsylvania 18702 Phone: (570) 829-1826 | |
Doctor Butler Eyecare, Llc Type: Medicare Supplier Location: 34 S Main St, Wilkes Barre, Pennsylvania 18701 Phone: (570) 822-8727 | |
Geisinger Multi-spec Clinic Podiatr Type: Medicare Supplier Location: 1155 E Mountain Blvd, Wilkes Barre, Pennsylvania 18702 Phone: (570) 214-5096 | |
Geisinger Wyoming Valley Type: Medicare Supplier Location: 1175 E Mountain Blvd, Wilkes Barre, Pennsylvania 18702 Phone: (570) 808-1093 |